These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34801042)

  • 1. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
    Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting local control of bone metastases from radioresistant tumors treated with palliative external beam radiotherapy.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Discov Oncol; 2023 May; 14(1):74. PubMed ID: 37212949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control after palliative external beam radiotherapy for bone metastases in patients with favorable prognosis.
    Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Mol Clin Oncol; 2022 Nov; 17(5):152. PubMed ID: 36237604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
    Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
    Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience.
    Heianna J; Toita T; Endo W; Kasuya G; Ariga T; Hashimoto S; Maemoto H; Terui K; Miura N; Togashi A; Miyauchi T; Murayama S
    Ann Nucl Med; 2015 Dec; 29(10):848-53. PubMed ID: 26266885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Kozuki T
    Oncol Lett; 2023 Jul; 26(1):303. PubMed ID: 37323814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
    Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
    Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.
    Grills IS; Hope AJ; Guckenberger M; Kestin LL; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Belderbos J
    J Thorac Oncol; 2012 Sep; 7(9):1382-93. PubMed ID: 22843086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    Lee YH; Lee JW; Jang HS
    BMC Cancer; 2017 Aug; 17(1):541. PubMed ID: 28800749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
    Ding M; Zollinger W; Ebeling R; Heard D; Posey R
    J Appl Clin Med Phys; 2018 Nov; 19(6):226-233. PubMed ID: 30216639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
    Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis.
    Coelho TM; Fogaroli RC; Pellizzon ACA; De Castro DG; Gondim GRM; Silva MLG; Chen MJ; Ramos H
    Radiat Oncol; 2018 Nov; 13(1):224. PubMed ID: 30454036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion.
    Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.